Ivax Generic Zoloft Exclusivity Will Be Unaffected By New FDA Guidance
Ivax expects to retain the full benefit of the 180-day generic exclusivity period for sertraline in 2006 if it prevails in a challenge of two of Pfizer's patents on Zoloft.
Ivax expects to retain the full benefit of the 180-day generic exclusivity period for sertraline in 2006 if it prevails in a challenge of two of Pfizer's patents on Zoloft.